EcoDrugPlus

Gamma-Secretase Subunit Pen-2

Ensembl ID : ENSOKIG00005001363
Gene Symbol: LOC109900877
3 Cross references
177 Possible Orthologues:

Glucagon Like Peptide 2 Receptor

Ensembl ID : ENSOKIG00005048594
Gene Symbol: GLP2R
2 Cross references
199 Possible Orthologues:

Glucagon Receptor

Ensembl ID : ENSOKIG00005031183
Gene Symbol: GCGR
1 Cross references
179 Possible Orthologues:

Glucagon Receptor

Ensembl ID : ENSOKIG00005038777
Gene Symbol: GCGR
3 Cross references
179 Possible Orthologues:

Glucagon-Like Peptide 2 Receptor

Ensembl ID : ENSOKIG00005046008
Gene Symbol: LOC109866067
2 Cross references
195 Possible Orthologues:

Glucocorticoid Receptor

Ensembl ID : ENSOKIG00005008463
Gene Symbol: LOC109878352
3 Cross references
200 Possible Orthologues:

Glucokinase

Ensembl ID : ENSOKIG00005041341
Gene Symbol: GCK
3 Cross references
205 Possible Orthologues:

Glucosylceramidase Beta 1

Ensembl ID : ENSOKIG00005042013
Gene Symbol: GBA1
1 Cross references
247 Possible Orthologues:

Glutamate Ionotropic Receptor Ampa Type Subunit 1

Ensembl ID : ENSOKIG00005027322
Gene Symbol: GRIA1
3 Cross references
243 Possible Orthologues:

Glutamate Ionotropic Receptor Ampa Type Subunit 2

Ensembl ID : ENSOKIG00005045914
Gene Symbol: GRIA2
3 Cross references
238 Possible Orthologues:

Glutamate Ionotropic Receptor Ampa Type Subunit 2

Ensembl ID : ENSOKIG00005040966
Gene Symbol: GRIA2
3 Cross references
237 Possible Orthologues:

Glutamate Ionotropic Receptor Ampa Type Subunit 2

Ensembl ID : ENSOKIG00005009055
Gene Symbol: GRIA2
3 Cross references
220 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).